Provenance_biocompute_object_example.json

Provenance for Biocompute object examples

{
  "resourceType": "Provenance",
  "id": "obj.1001",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: obj.1001</p><p><b>target</b>: <a>Procedure/example/_history/1.2</a></p><p><b>period</b>: 06/06/2017 --&gt; (ongoing)</p><p><b>recorded</b>: 09/06/2016 8:12:14 AM</p><p><b>reason</b>: antiviral resistance detection (Details: [not stated] code null = 'null', stated as 'antiviral resistance detection')</p><p><b>policy</b>: <a>https://github.com/common-workflow-language/workflows/blob/master/workflows/lobSTR/lobSTR-workflow.cwl</a></p><blockquote><p><b>agent</b></p><p><b>role</b>: Author (Details: http://hl7.org/fhir/provenance-participant-role code author = 'Author', stated as 'null')</p><p><b>who</b>: <a>Practitioner/f204</a></p></blockquote><blockquote><p><b>agent</b></p><p><b>role</b>: Author (Details: http://hl7.org/fhir/provenance-participant-role code author = 'Author', stated as 'null')</p><p><b>who</b>: <a>Practitioner/f006</a></p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Identify baseline single nucleotide polymorphisms (SNPs[SO:0000694]), insertions[SO:0000667], and deletions[SO:0000045] that correlate with reduced ledipasvir[PubChem:67505836] antiviral drug efficacy in Hepatitis C virus subtype 1</p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Identify treatment emergent amino acid substitutions[SO:0000048] that correlate with antiviral drug treatment failure</p></blockquote><blockquote><p><b>entity</b></p><p><b>role</b>: quotation</p><p><b>reference</b>: Determine whether the treatment emergent amino acid    substitutions[SO:0000048] identified correlate with treatment failure    involving other drugs against the same virus</p></blockquote></div>"
  },
  "target": [
    {
      "reference": "Procedure/example/_history/1.2"
    }
  ],
  "period": {
    "start": "2017-06-06"
  },
  "recorded": "2016-06-09T08:12:14+10:00",
  "reason": [
    {
      "display": "antiviral resistance detection"
    }
  ],
  "policy": [
    "https://github.com/common-workflow-language/workflows/blob/master/workflows/lobSTR/lobSTR-workflow.cwl"
  ],
  "agent": [
    {
      "role": {
        "system": "http://hl7.org/fhir/provenance-participant-role",
        "code": "author"
      },
      "whoReference": {
        "reference": "Practitioner/f204"
      }
    },
    {
      "role": {
        "system": "http://hl7.org/fhir/provenance-participant-role",
        "code": "author"
      },
      "whoReference": {
        "reference": "Practitioner/f006"
      }
    }
  ],
  "entity": [
    {
      "role": "quotation",
      "reference": {
        "display": "Identify baseline single nucleotide polymorphisms (SNPs[SO:0000694]), insertions[SO:0000667], and deletions[SO:0000045] that correlate with reduced ledipasvir[PubChem:67505836] antiviral drug efficacy in Hepatitis C virus subtype 1"
      }
    },
    {
      "role": "quotation",
      "reference": {
        "display": "Identify treatment emergent amino acid substitutions[SO:0000048] that correlate with antiviral drug treatment failure"
      }
    },
    {
      "role": "quotation",
      "reference": {
        "display": "Determine whether the treatment emergent amino acid    substitutions[SO:0000048] identified correlate with treatment failure    involving other drugs against the same virus"
      }
    }
  ]
}